Summary
Oncology center transactions have become increasingly common as industry reimbursement changes and regulatory pressures grow. The valuation of these centers can prove challenging due to the specialized nature of the oncology industry, and the necessity of ensuring that affiliations and partnerships with outside entities meet the stringent standards of fair market value and commercial reasonableness. Join renowned experts William Hamilton and Tynan Olechny, both of PYA, as they reveal the nuanced considerations essential to valuing oncology businesses.
Valuing Oncology Centers
PDF, Size: 4,244 KB